-
1
-
-
0442268112
-
A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less
-
Hammer SM, Squires KE, Hughes MD et al. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. N Engl J Med 1997; 337: 725-33.
-
(1997)
N Engl J Med
, vol.337
, pp. 725-733
-
-
Hammer, S.M.1
Squires, K.E.2
Hughes, M.D.3
-
2
-
-
0032507027
-
Improved survival among HIV-infected individuals following initiation of antiretroviral therapy
-
Hogg RS, Heath KV, Yip B et al. Improved survival among HIV-infected individuals following initiation of antiretroviral therapy. JAMA 1998; 279: 450-4.
-
(1998)
JAMA
, vol.279
, pp. 450-454
-
-
Hogg, R.S.1
Heath, K.V.2
Yip, B.3
-
3
-
-
2442723342
-
Treatment of human immunodeficiency virus infection with saquinavir, zidovudine and zalcitabine
-
Collier AC, Coombs RW, Schoenfeld DA et al. Treatment of human immunodeficiency virus infection with saquinavir, zidovudine and zalcitabine. N Engl J Med 1996; 334: 1011-7.
-
(1996)
N Engl J Med
, vol.334
, pp. 1011-1017
-
-
Collier, A.C.1
Coombs, R.W.2
Schoenfeld, D.A.3
-
4
-
-
48949097660
-
Antiretroviral treatment of adult HIV infection. 2008 recommendations of the International AIDS Society-USA panel
-
Hammer SM, Eron JJ, Reiss P et al. Antiretroviral treatment of adult HIV infection. 2008 recommendations of the International AIDS Society-USA panel. JAMA 2008; 300: 555-70.
-
(2008)
JAMA
, vol.300
, pp. 555-570
-
-
Hammer, S.M.1
Eron, J.J.2
Reiss, P.3
-
5
-
-
59649092052
-
Drug-resistant human immunodefiency virus
-
Kozal MJ. Drug-resistant human immunodefiency virus. Clin Microbiol Infect 2009; 15 Suppl 1: 69-73.
-
(2009)
Clin Microbiol Infect
, vol.15
, Issue.SUPPL. 1
, pp. 69-73
-
-
Kozal, M.J.1
-
6
-
-
58149522617
-
Broad advances in understanding HIV resistance to antiretrovirals: report on the XVII International HIV Drug Resistance Workshop
-
Mascolini M, Larder BA, Boucher CA et al. Broad advances in understanding HIV resistance to antiretrovirals: report on the XVII International HIV Drug Resistance Workshop. Antivir Ther 2008; 13: 1097-113.
-
(2008)
Antivir Ther
, vol.13
, pp. 1097-1113
-
-
Mascolini, M.1
Larder, B.A.2
Boucher, C.A.3
-
7
-
-
23244454080
-
The global status of resistance to antiretroviral drugs
-
Vella S, Palmisano L. The global status of resistance to antiretroviral drugs. Clin Infect Dis 2005; 41 Suppl 4: S239-46.
-
(2005)
Clin Infect Dis
, vol.41
, Issue.SUPPL. 4
-
-
Vella, S.1
Palmisano, L.2
-
8
-
-
0038234808
-
Antiretroviral drug resistance testing in adults infected with human immunodeficiency virus type 1: 2003 Recommendations of an International AIDS Society-USA panel
-
Hirsch MS, Brun-Vézinet FB, Clotet B et al. Antiretroviral drug resistance testing in adults infected with human immunodeficiency virus type 1: 2003 Recommendations of an International AIDS Society-USA panel. Clin Infect Dis 2003; 37: 113-28.
-
(2003)
Clin Infect Dis
, vol.37
, pp. 113-128
-
-
Hirsch, M.S.1
Brun-Vézinet, F.B.2
Clotet, B.3
-
9
-
-
19944403922
-
Updated European recommendations for the clinical use of HIV drug resistance testing
-
Vandamme A-M, Sönnerborg A, Ait-Khaled M et al. Updated European recommendations for the clinical use of HIV drug resistance testing. Antivir Ther 2004; 9: 829-48.
-
(2004)
Antivir Ther
, vol.9
, pp. 829-848
-
-
Vandamme, A.-M.1
Sönnerborg, A.2
Ait-Khaled, M.3
-
10
-
-
77950229001
-
Changes in the use of HIV antiretroviral resistance testing in a large cohort of U.S. patients, 1999 to 2006
-
Buchacz K, Baker RK, Young B et al. Changes in the use of HIV antiretroviral resistance testing in a large cohort of U.S. patients, 1999 to 2006. J Acquir Immune Defic Syndr 2010; 53: 625-32.
-
(2010)
J Acquir Immune Defic Syndr
, vol.53
, pp. 625-632
-
-
Buchacz, K.1
Baker, R.K.2
Young, B.3
-
11
-
-
79952805959
-
Predictors of having a resistance test following viral load (VL) failure of cART: data from EuroSIDA
-
Cologne, Germany
-
Fox Z, Phillips AN, Cozzi-Lepri A et al. Predictors of having a resistance test following viral load (VL) failure of cART: data from EuroSIDA. The 12th European AIDS Conference/EACS, Cologne, Germany, 2009. Abstract PE3.1/2.
-
(2009)
The 12th European AIDS Conference/EACS
-
-
Fox, Z.1
Phillips, A.N.2
Cozzi-Lepri, A.3
-
12
-
-
17144369901
-
Long term probability of detection of HIV-1 drug resistance after starting antiretroviral therapy in routine clinical practice
-
Phillips AN, Dunn D, Sabin C et al. Long term probability of detection of HIV-1 drug resistance after starting antiretroviral therapy in routine clinical practice. AIDS 2005; 19: 487-94.
-
(2005)
AIDS
, vol.19
, pp. 487-494
-
-
Phillips, A.N.1
Dunn, D.2
Sabin, C.3
-
13
-
-
67649147982
-
Evolution and predictors of HIV type-1 drug resistance in patients failing combination antiretroviral therapy in Italy
-
Di Giambenedetto S, Zazzi M, Corsi P et al. Evolution and predictors of HIV type-1 drug resistance in patients failing combination antiretroviral therapy in Italy. Antivir Ther 2009; 14: 359-69.
-
(2009)
Antivir Ther
, vol.14
, pp. 359-369
-
-
Di Giambenedetto, S.1
Zazzi, M.2
Corsi, P.3
-
14
-
-
24644500647
-
Estimating HIV-1 drug resistance in antiretroviral-treated individuals in the United Kingdom
-
Pillay D, Green H, Matthias R et al. Estimating HIV-1 drug resistance in antiretroviral-treated individuals in the United Kingdom. J Infect Dis 2005; 192: 967-73.
-
(2005)
J Infect Dis
, vol.192
, pp. 967-973
-
-
Pillay, D.1
Green, H.2
Matthias, R.3
-
15
-
-
0035964694
-
Changes in the rate of genotypic resistance to antiretroviral drugs in Spain
-
Gallego O, Ruiz L, Vallejo A et al. Changes in the rate of genotypic resistance to antiretroviral drugs in Spain. AIDS 2001; 15: 1894-6.
-
(2001)
AIDS
, vol.15
, pp. 1894-1896
-
-
Gallego, O.1
Ruiz, L.2
Vallejo, A.3
-
16
-
-
60449087073
-
Nine-year trends in clinically relevant reduced susceptibility of HIV-1 to antiretrovirals
-
Sista P, Rinehart AR, Wasikowski B et al. Nine-year trends in clinically relevant reduced susceptibility of HIV-1 to antiretrovirals. J Clin Virol 2009; 44: 190-4.
-
(2009)
J Clin Virol
, vol.44
, pp. 190-194
-
-
Sista, P.1
Rinehart, A.R.2
Wasikowski, B.3
-
17
-
-
0742269873
-
Resistance of HIV-1 to multiple antiretroviral drugs in France: a 6-year survey (1997-2002) based on an analysis of over 7000 genotypes
-
Tamalet C, Fantini J, Tourres C et al. Resistance of HIV-1 to multiple antiretroviral drugs in France: a 6-year survey (1997-2002) based on an analysis of over 7000 genotypes. AIDS 2003; 17: 2383-8.
-
(2003)
AIDS
, vol.17
, pp. 2383-2388
-
-
Tamalet, C.1
Fantini, J.2
Tourres, C.3
-
18
-
-
3142660152
-
The prevalence ofantiretroviral drug resistance in the United States
-
Richman DD, Morton SC, Wrin T et al. The prevalence ofantiretroviral drug resistance in the United States. AIDS 2004; 18: 1393-401.
-
(2004)
AIDS
, vol.18
, pp. 1393-1401
-
-
Richman, D.D.1
Morton, S.C.2
Wrin, T.3
-
19
-
-
34547927815
-
Changing rates and patterns of drug resistance mutations in antiretroviral-experienced HIV-infected patients
-
De Mendoza C, Garrido C, Corral A et al. Changing rates and patterns of drug resistance mutations in antiretroviral-experienced HIV-infected patients. AIDS Res Hum Retroviruses 2007; 23: 879-85.
-
(2007)
AIDS Res Hum Retroviruses
, vol.23
, pp. 879-885
-
-
De Mendoza, C.1
Garrido, C.2
Corral, A.3
-
20
-
-
79952782160
-
-
(9 October 2010, date last accessed)
-
Kirk O, Mocroft A, Lundgren JD et al. EuroSIDA amulticentre study, 1994-2009. http://www.cphiv.dk/EuroSIDA/Publications/EuroSIDAamulticentrestudy1994-2009/tabid/407/Default.aspx (9 October 2010, date last accessed).
-
(1994)
EuroSIDA amulticentre study
-
-
Kirk, O.1
Mocroft, A.2
Lundgren, J.D.3
-
21
-
-
0027122957
-
1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults
-
CDC
-
CDC. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep 1992; 41: 1-19.
-
(1992)
MMWR Morb Mortal Wkly Rep
, vol.41
, pp. 1-19
-
-
-
22
-
-
79952801290
-
-
Stanford University HIV Drug Resistance Database. (9 October, date last accessed)
-
Stanford University HIV Drug Resistance Database. HIVdb Program Genotypic Resistance Interpretation Algorithm. http://hivdb.stanford.edu/pages/algs/HIVdb.html (9 October 2010, date last accessed).
-
(2010)
HIVdb Program Genotypic Resistance Interpretation Algorithm
-
-
-
23
-
-
40649106525
-
The incidence of multidrug and full class resistance in HIV-1 infected patients is decreasing over time (2001-2006) in Portugal
-
Vercauteren J, Deforche K, Theys K et al. The incidence of multidrug and full class resistance in HIV-1 infected patients is decreasing over time (2001-2006) in Portugal. Retrovirology 2008; 1: 5-12.
-
(2008)
Retrovirology
, vol.1
, pp. 5-12
-
-
Vercauteren, J.1
Deforche, K.2
Theys, K.3
-
24
-
-
72249107557
-
The incidence rate of HIV type-1 drug resistance in patients on antiretroviral therapy: a nationwide population-based Danish cohort study 1999-2005
-
Audelin AM, Lohse N, Obel N et al. The incidence rate of HIV type-1 drug resistance in patients on antiretroviral therapy: a nationwide population-based Danish cohort study 1999-2005. Antivir Ther 2009; 14: 995-1000.
-
(2009)
Antivir Ther
, vol.14
, pp. 995-1000
-
-
Audelin, A.M.1
Lohse, N.2
Obel, N.3
-
25
-
-
34848844088
-
Prevalence of HIV-1 drug resistance in treated patients. A French nationwide study
-
Costagliola D, Descamps D, Assoumou L et al. Prevalence of HIV-1 drug resistance in treated patients. A French nationwide study. J Acquir Immune Defic Syndr 2007; 46: 12-8.
-
(2007)
J Acquir Immune Defic Syndr
, vol.46
, pp. 12-18
-
-
Costagliola, D.1
Descamps, D.2
Assoumou, L.3
-
26
-
-
12144290307
-
Surveillance of HIV antiretroviral drug resistance in treated individuals in England: 1998-2000
-
Scott P, Arnold E, Evans B et al. Surveillance of HIV antiretroviral drug resistance in treated individuals in England: 1998-2000. J Antimicrob Chemother 2004; 53: 469-73.
-
(2004)
J Antimicrob Chemother
, vol.53
, pp. 469-473
-
-
Scott, P.1
Arnold, E.2
Evans, B.3
-
27
-
-
33747805631
-
Drug-class-wide resistance to antiretrovirals in HIV-infected patients failing therapy: prevalence, risk factors and virological outcome
-
Tozzi V, Zaccarelli M, Bonfigli S et al. Drug-class-wide resistance to antiretrovirals in HIV-infected patients failing therapy: prevalence, risk factors and virological outcome. Antivir Ther 2006; 11: 553-60.
-
(2006)
Antivir Ther
, vol.11
, pp. 553-560
-
-
Tozzi, V.1
Zaccarelli, M.2
Bonfigli, S.3
-
29
-
-
63649085185
-
Long-term trends of HIV type 1 drug resistance prevalence among antiretroviral treatment-experienced patients in Switzerland
-
Von Wyl V, Yerly S, Burgisser P et al. Long-term trends of HIV type 1 drug resistance prevalence among antiretroviral treatment-experienced patients in Switzerland. Clin Infect Dis 2009; 48: 979-87.
-
(2009)
Clin Infect Dis
, vol.48
, pp. 979-987
-
-
Von Wyl, V.1
Yerly, S.2
Burgisser, P.3
-
30
-
-
77955009720
-
Methods for estimating the prevalence of multidrug resistance in antiretroviral therapy-experienced patients in North America
-
San Francisco, CA Abstract 584. Foundation for Retrovirology and Human Health, Alexandria, VA, USA
-
Abraham AG, Gange SJ, Moore RD et al. Methods for estimating the prevalence of multidrug resistance in antiretroviral therapy-experienced patients in North America. In: Abstracts of the Seventeenth Conference on Retroviruses and Opportunistic Infections, San Francisco, CA, 2010. Abstract 584. Foundation for Retrovirology and Human Health, Alexandria, VA, USA.
-
(2010)
Abstracts of the Seventeenth Conference on Retroviruses and Opportunistic Infections
-
-
Abraham, A.G.1
Gange, S.J.2
Moore, R.D.3
-
32
-
-
0000125534
-
Sample selection bias as a specification error
-
Heckman J. Sample selection bias as a specification error. Econometrica 1979; 47: 153-61.
-
(1979)
Econometrica
, vol.47
, pp. 153-161
-
-
Heckman, J.1
|